Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Axsome Therapeutics Inc AXSM

Healthcare Biotechnology
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in developing and delivering therapies for central nervous system (CNS), conditions that have limited treatment options. The Company's two commercial products and development programs are Auvelity and Sunosi. Auvelity (dextromethorphan-bupropion) is an oral, N-methyl-D-aspartate (NMDA) receptor... see more

Recent & Breaking News (NDAQ:AXSM)

28 Stocks Moving In Thursday's Pre-Market Session

Benzinga.com  January 10, 2019

56 Biggest Movers From Yesterday

Benzinga.com  January 10, 2019

45 Stocks Moving In Wednesday's Mid-Day Session

Benzinga.com  January 9, 2019

22 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  January 9, 2019

38 Stocks Moving In Tuesday's Mid-Day Session

Benzinga.com  January 8, 2019

Mid-Morning Market Update: Markets Open Higher; Helen of Troy Beats Q3 Estimates

Benzinga.com  January 8, 2019

Thinking about buying stock in Apple, Axsome Therapeutics, Luxoft, Netflix or QEP Resources?

PR Newswire January 8, 2019

65 Biggest Movers From Yesterday

Benzinga.com  January 8, 2019

Axsome Therapeutics Raises $23.3 Million Under Existing ATM Facility

GlobeNewswire January 7, 2019

42 Stocks Moving In Monday's Mid-Day Session

Benzinga.com  January 7, 2019

Mid-Day Market Update: Luxoft Jumps On Acquisition News; PG&E Shares Tumble

Benzinga.com  January 7, 2019

21 Stocks Moving In Monday's Pre-Market Session

Benzinga.com  January 7, 2019

Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in Phase 2 Trial in Major Depressive Disorder

GlobeNewswire January 7, 2019

The Week Ahead In Biotech: Conferences, Clinical Trials

Benzinga.com  January 6, 2019

50 Biggest Movers From Monday

Benzinga.com  January 2, 2019

New Research: Key Drivers of Growth for Trimble, Maxar Technologies, MagnaChip Semiconductor, Palo Alto Networks, AAR, and Axsome Therapeutics — Factors of Influence, Major Initiatives and Sustained Production

GlobeNewswire December 31, 2018

Axsome Therapeutics Provides Year End 2018 Clinical Update

GlobeNewswire December 27, 2018

Axsome Therapeutics to Present at Biotech Showcase 2019

GlobeNewswire December 18, 2018

46 Biggest Movers From Yesterday

Benzinga.com  December 11, 2018

A Tale Of 2 Biotechs: Axsome, Axovant Report Contrasting Outcomes For Neurologic Drugs

Benzinga.com  December 10, 2018